Cargando…
Genetic and Epigenetic Host–Virus Network to Investigate Pathogenesis and Identify Biomarkers for Drug Repurposing of Human Respiratory Syncytial Virus via Real-World Two-Side RNA-Seq Data: Systems Biology and Deep-Learning Approach
Human respiratory syncytial virus (hRSV) affects more than 33 million people each year, but there are currently no effective drugs or vaccines approved. In this study, we first constructed a candidate host–pathogen interspecies genome-wide genetic and epigenetic network (HPI-GWGEN) via big-data mini...
Autores principales: | Hsu, Bo-Wei, Chen, Bor-Sen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295364/ https://www.ncbi.nlm.nih.gov/pubmed/37371627 http://dx.doi.org/10.3390/biomedicines11061531 |
Ejemplares similares
-
Host Components Contributing to Respiratory Syncytial Virus Pathogenesis
por: Carvajal, Jonatan J., et al.
Publicado: (2019) -
Respiratory Syncytial Virus Infection Morbidity in the Elderly: Time for Repurposing of Ribavirin?
por: de Zwart, Auke E S, et al.
Publicado: (2020) -
Respiratory Syncytial Virus (RSV) Modulation at the Virus-Host Interface Affects Immune Outcome and Disease Pathogenesis
por: Tripp, Ralph A.
Publicado: (2013) -
Receptors for Respiratory Syncytial Virus Infection and Host Factors Regulating the Life Cycle of Respiratory Syncytial Virus
por: Feng, Ziheng, et al.
Publicado: (2022) -
Host Responses to Respiratory Syncytial Virus Infection
por: Agac, Ayse, et al.
Publicado: (2023)